BioGaia AB (publ) BioGaia AB (publ)

BioGaia AB (publ)

BIOG-B

Rang in aandelen #8084
BioGaia AB (publ), a Swedish enterprise founded in 1990 and headquartered in... BioGaia AB (publ), a Swedish enterprise founded in 1990 and headquartered in Stockholm, is dedicated to the worldwide development, marketing, and distribution of probiotic products renowned for their scientifically proven health advantages. The company operates through three primary divisions. Its Pediatrics segment offers various items such as drops, oral rehydration solutions, and gut health tablets, in addition to supplying cultures for integration into infant formula. The Adult Health segment provides gut health tablets and oral health lozenges, alongside furnishing cultures to licensees for use in dairy products. A third segment, "Other," specializes in packaging solutions. BioGaia's extensive product portfolio targets a range of health issues, including infantile colic and digestive health in children, antibiotic-associated and acute diarrhea, gingivitis, periodontal disease, general well-being, Helicobacter pylori bacterial infections (linked to gastric ulcers), and concerns related to low bone density. All of its offerings are sold exclusively under the BioGaia brand.
Aandeelprijs
$12.97
Marktkapitalisatie
$1.28B
Verandering (1 dag)
2.97%
Verandering (1 jaar)
13.76%
Land
SE
Handel BioGaia AB (publ) (BIOG-B)

Categorie

Healthcare
Koersgeschiedenis voor BioGaia AB (publ) (BIOG-B)
Hoogste slotkoers: $12.35 op 2026-10-01

Laagste slotkoers: $6.50 op 2015-09-01
Koersgeschiedenis van BioGaia AB (publ) van 2015 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) 6.08%
2025 -0.98%
2024 9.23%
2023 17.14%
2022 -25.15%
2021 -12.80%
2020 58.73%
2019 5.53%
2018 53.85%
2016 -32.67%
2015 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$171.67 -
DE
$165.25 23.58%
DE
$40.45 43.11%
JP
$226.14 32.06%
CH
$18.43 -4.03%
IN